Baker Bros. Advisors LP Acadia Pharmaceuticals Inc Transaction History
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
A detailed history of Baker Bros. Advisors LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 42,877,916 shares of ACAD stock, worth $736 Million. This represents 7.07% of its overall portfolio holdings.
Number of Shares
42,877,916
Previous 42,877,916
-0.0%
Holding current value
$736 Million
Previous $697 Million
5.29%
% of portfolio
7.07%
Previous 9.26%
Shares
12 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Vanguard Group Inc Valley Forge, PA13.8MShares$238 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$235 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$103 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.5MShares$60.2 Million0.05% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.78B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...